Companies · Other Health Care

Ebh Holding Company, Inc.

LONG BEACH · Other Health Care

Diligence memoA one-page analyst read on Ebh Holding Company, Inc. — recommendation, valuation, rhythm, risks.
$70.9M
Total raised · real
7
Rounds
0.2×
Latest step-up
Top 7%
Sector rank · raised
Series B
Latest stage · inferred · Mon Nov 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Ebh Holding Company, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.97× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era.
Dormant
  • Last raise 10.6 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Ebh Holding Company, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
13.9 yr record
Peak capital year was 2015 with $331.0M across 17 filings.
Market position
ahead of 94% of Other Health Care peers
Capital scale is ahead of 94% of Other Health Care peers; modeled value is above 96% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2015: $331.0M across 17 filings.
  • Largest single filing was $39.3M on 2015-11-16.
  • Filing rows sum to $341.1M, while canonical raised total is $70.9M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Ebh Holding Company, Inc. is one of 5377 Other Health Care companies tracked from LONG BEACH. By capital raised it ranks among the largest (ahead of 94% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2015-11-16
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2012-08-15 Raised $10M (real) Modeled valuation $202M (est)Series A2012Series A · 2013-06-03 Raised $100K (real) Modeled valuation $2.0M (est)Series A · 2015-02-13 Raised $4.0M (real) Modeled valuation $81M (est)Series A2015Series A · 2015-05-22 Raised $12M (real) Modeled valuation $252M (est)Seed · 2015-05-22 Raised $4.0M (real) Modeled valuation $99M (est)Seed2015Series A · 2015-07-22 Raised $3.0M (real) Modeled valuation $61M (est)Series A · 2015-09-08 Raised $2.0M (real) Modeled valuation $40M (est)Series A2015Series B · 2015-11-16 Raised $22M (real) Modeled valuation $487M (est)Series A · 2015-11-16 Raised $14M (real) Modeled valuation $282M (est)Series A2015Series B · 2015-11-16 Raised $36M (real) Modeled valuation $794M (est)Series B · 2015-11-16 Raised $38M (real) Modeled valuation $849M (est)Series B2015Series B · 2015-11-16 Raised $31M (real) Modeled valuation $694M (est)Series A · 2015-11-16 Raised $9.9M (real) Modeled valuation $201M (est)Series A2015Series B · 2015-11-16 Raised $39M (real) Modeled valuation $871M (est)Series B · 2015-11-16 Raised $18M (real) Modeled valuation $398M (est)Series B2015Series B · 2015-11-16 Raised $27M (real) Modeled valuation $605M (est)Series B · 2015-11-16 Raised $30M (real) Modeled valuation $661M (est)Series B2015Series B · 2015-11-16 Raised $34M (real) Modeled valuation $749M (est)Series A · 2015-11-16 Raised $5.9M (real) Modeled valuation $119M (est)Series A2015Cumulative $341M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$10.0M · 2012
Series A extension$100K · 2013
Series A extension$4.0M · 2015
Series A extension$12.5M · 2015
Bridge · Series A-stage$4.0M · 2015smaller follow-on
Series A extension$3.0M · 2015
Series A extension$2.0M · 2015
Series B$22.0M · 2015
Bridge · Series B-stage$14.0M · 2015smaller follow-on
Series B extension$35.8M · 2015
Series B extension$38.3M · 2015
Series B extension$31.3M · 2015
Bridge · Series B-stage$9.9M · 2015smaller follow-on
Series B extension$39.3M · 2015
Series B extension$18.0M · 2015
Series B extension$27.3M · 2015
Series B extension$29.8M · 2015
Series B extension$33.8M · 2015
Bridge · Series B-stage$5.9M · 2015smaller follow-on

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$871.1M
Base estimate est.
$92.4M
Conservative case
$3.4B
Upside case
$218.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $201.8M · 2012-08-152012Series A · modeled $2.0M · 2013-06-03Series A · modeled $80.7M · 2015-02-13Series A · modeled $252.0M · 2015-05-22Seed · modeled $99.1M · 2015-05-22Series A · modeled $60.5M · 2015-07-22Series A · modeled $40.4M · 2015-09-08Series B · modeled $486.6M · 2015-11-16Series A · modeled $281.7M · 2015-11-16Series B · modeled $793.5M · 2015-11-16Series B · modeled $848.9M · 2015-11-16Series B · modeled $693.8M · 2015-11-16Series A · modeled $200.6M · 2015-11-16Series B · modeled $871.1M · 2015-11-16Series B · modeled $398.1M · 2015-11-16Series B · modeled $605.2M · 2015-11-16Series B · modeled $660.6M · 2015-11-16Series B · modeled $749.2M · 2015-11-16Series A · modeled $119.1M · 2015-11-162015
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
10.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
2 mo
Avg between rounds
$21.8M/yr
Capital velocity
13.9 yr
On record since
2012
First round
19
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 29× above median
This company$70.9M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.3× of median
This company$5.9M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 39× above median
This company$871.1M
Sector median$22.1M

Raised more than 94% of sector peers (real $). Modeled value above 96% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #3 of 85.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Drynachan, Llc · Series B Raised $40.0M · modeled $886.2M (est)Vistria SHC Holdings, LLC · Series B Raised $39.7M · modeled $879.5M (est)Orthopediatrics Corp · Series B Raised $57.5M · modeled $864.0M (est)Assurerx Health, Inc · Series B Raised $51.5M · modeled $828.4M (est)IMRIS Inc. · Series B Raised $36.8M · modeled $816.0M (est)Remedy Partners, Inc. · Series B Raised $56.4M · modeled $795.3M (est)Hansen Medical Inc · Series B Raised $126.0M · modeled $775.4M (est)BCOM Investment Partners, LLC · Series B Raised $34.5M · modeled $764.3M (est)Michigan Critical Care Consultants, Inc. · Series B Raised $34.0M · modeled $753.2M (est)HY Holdings, Inc. · Series B Raised $33.0M · modeled $731.1M (est)Medical Solutions L.L.C. · Series B Raised $32.5M · modeled $720.0M (est)Ebh Holding Company, Inc. (this company) Raised $70.9M · modeled $871.1M (est)Ebh Holding Company, Inc.
CompanyStageRaised · realValue · estvs peer med.
Drynachan, LlcSeries B$40.0M$886.2M2.00×
Vistria SHC Holdings, LLCSeries B$39.7M$879.5M1.99×
Ebh Holding Company, Inc. this companySeries B$70.9M$871.1M1.97×
Orthopediatrics CorpSeries B$57.5M$864.0M1.95×
Assurerx Health, IncSeries B$51.5M$828.4M1.87×
IMRIS Inc.Series B$36.8M$816.0M1.84×
Remedy Partners, Inc.Series B$56.4M$795.3M1.79×
Hansen Medical IncSeries B$126.0M$775.4M1.75×
BCOM Investment Partners, LLCSeries B$34.5M$764.3M1.72×
Michigan Critical Care Consultants, Inc.Series B$34.0M$753.2M1.70×
HY Holdings, Inc.Series B$33.0M$731.1M1.65×
Medical Solutions L.L.C.Series B$32.5M$720.0M1.62×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$10.0M2012-08-15$45.5M$201.8M85%
Series A$100K2013-06-03$455K$2.0M85%
Series A$4.0M2015-02-13$18.2M$80.7M85%
Series A$12.5M2015-05-22$56.8M$252.0M85%
Seed$4.0M2015-05-22$20.0M$99.1M85%
Series A$3.0M2015-07-22$13.6M$60.5M85%
Series A$2.0M2015-09-08$9.1M$40.4M85%
Series B$22.0M2015-11-16$122.0M$486.6M85%
Series A$14.0M2015-11-16$63.5M$281.7M85%
Series B$35.8M2015-11-16$199.0M$793.5M90%
Series B$38.3M2015-11-16$212.9M$848.9M90%
Series B$31.3M2015-11-16$174.0M$693.8M90%
Series A$9.9M2015-11-16$45.2M$200.6M85%
Series B$39.3M2015-11-16$218.4M$871.1M90%
Series B$18.0M2015-11-16$99.8M$398.1M85%
Series B$27.3M2015-11-16$151.8M$605.2M85%
Series B$29.8M2015-11-16$165.7M$660.6M85%
Series B$33.8M2015-11-16$187.9M$749.2M90%
Series A$5.9M2015-11-16$26.8M$119.1M85%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$10.0M2012-08-15
    • First recorded raise — entered as Series A.
    • 13 investors on this round.
  2. Series A$100K2013-06-03
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 100.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  3. Series A$4.0M2015-02-13
    • Raised 20 mo later, in step with the ~14 mo sector norm.
    • Round 40.0× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 17 investors on this round.
  4. Series A$12.5M2015-05-22
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 3.1× larger than the prior — scaling up.
    • 12 investors on this round.
  5. Seed$4.0M2015-05-22
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.1× smaller than the prior — bridge or down round.
    • 12 investors on this round.
  6. Series A$3.0M2015-07-22
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  7. Series A$2.0M2015-09-08
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 7 investors on this round.
  8. Series B$22.0M2015-11-16
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 11.0× larger than the prior — scaling up.
    • 8 investors on this round.
  9. Series A$14.0M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  10. Series B$35.8M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.6× larger than the prior — scaling up.
    • 8 investors on this round.
  11. Series B$38.3M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 8 investors on this round.
  12. Series B$31.3M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 8 investors on this round.
  13. Series A$9.9M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.2× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  14. Series B$39.3M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.0× larger than the prior — scaling up.
    • 8 investors on this round.
  15. Series B$18.0M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.2× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  16. Series B$27.3M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
    • 8 investors on this round.
  17. Series B$29.8M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 8 investors on this round.
  18. Series B$33.8M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 8 investors on this round.
  19. Series A$5.9M2015-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 5.7× smaller than the prior — bridge or down round.
    • 7 investors on this round.
Intelligence
2016 ~Q1
Modeled next raise · ~2mo cadence
$5.9M
Modeled next size est.range $5.9M$9.4M
0.2×
Last step-up
$21.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Mohamad Makhzoumi9 other2012-08
Nader Naini5 other2012-08
Thomas Cooper5 other2012-08
Richard Whitney4 other2012-08
Greg Scott2 other2015-11
Jennifer Gallagher2 other2015-02
Chris Karkenny1 other2015-09
David Kosloff1 other2012-08
David Sack1 other2012-08
Jim Adams1 other2013-06
Rob Mahan1 other2012-08
David Sack, M.D.2015-05
Keith Arnold2015-02
Vera Appleyard2015-02
Registry & provenance

Ebh Holding Company, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1556494
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Elements Behavioral Health, Inc.Other Health CareSeries C$165.2M$1.4Bnetwork7 shared operators · same sector
AristaMD, Inc.Other Health CareSeries B$71.2M$136.5Mnetwork1 shared operator · same sector · same stage
Docent Health, Inc.Other Health CareSeries B$17.1M$378.8Mnetwork1 shared operator · same sector · same stage
Radiology Partners Holdings, LLCOther Health CareGrowth/Late$1.5B$9.1Bnetwork2 shared operators · same sector
NinePoint Medical, Inc.Other Health CareSeries B$70.4M$679.4Msame sector · same stage
Audax Health Solutions, Inc.Other Health CareSeries B$70.4M$642.0Msame sector · same stage
Esperion Therapeutics, Inc.Other Health CareSeries B$72.7M$376.6Msame sector · same stage
Auxogyn IncOther Health CareSeries B$73.1M$327.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
ERBA Holdings, LLCOther Health CareSeries A$85.3M86%
CDRH Holding, Inc.Other Health CareSeries B$556.2M84%
JBK Holdings, LLCOther Health CareSeed$6.3M84%
Eisana CorpOther Health CareSeed$22.4M84%
MCH Ventures, Inc.Other Health CareSeed$7.1M84%
S&K Holdings, Inc.Other Health CareSeed$47.0M83%
Equiscript Holdings, Inc.Other Health CareSeed$5.6M83%
EGB VenturesOther Health CareSeries A$62.7M83%
Frequently asked
How much funding has Ebh Holding Company, Inc. raised?
Ebh Holding Company, Inc. has raised approximately $70.9M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is Ebh Holding Company, Inc.'s estimated valuation?
Provath's modeled valuation for Ebh Holding Company, Inc. is approximately $871.1M (modeled range $92.4M–$3.4B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Ebh Holding Company, Inc. at?
Ebh Holding Company, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Mon Nov 16.
What does Ebh Holding Company, Inc. do and where is it based?
Ebh Holding Company, Inc. operates in the Other Health Care sector, based in LONG BEACH.
Explore related

See where Ebh Holding Company, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Ebh Holding Company, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.